Disclosed is an immunity inducer comprising, as an active ingredient, a recombinant vector which comprises at least one polypeptide selected from the polypeptides (a) to (c) mentioned below and having an immunity-inducing activity or a polynucleotide encoding the at least one polypeptide and which can express the polypeptide : (a) a polypeptide which comprises at least seven contiguous amino acid residues contained in an amino acid sequence represented by SEQ ID NO:2, SEQ ID NO:4, SEQ ID NO:6, SEQ ID NO:8, SEQ ID NO:10, SEQ ID NO:12 or SEQ ID NO:44 shown in the Sequence Listing； (b) a polypeptide which has a 90% or more sequence identity with the polypeptide (a) and comprises at least seven amino acid residues； and (c) a polypeptide which contains the polypeptide (a) or (b) as a partial sequence thereof. The immunity inducer is useful as a therapeutic and/or prophylactic agent for cancer or the like.
